首页> 外国专利> CRYSTALLINE POLYMORPH OF A BISULFATE SALT OF A THROMBIN RECEPTOR ANTAGONIST, PROCESS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING THROMBIN RECEPTORS

CRYSTALLINE POLYMORPH OF A BISULFATE SALT OF A THROMBIN RECEPTOR ANTAGONIST, PROCESS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING THROMBIN RECEPTORS

机译:凝血酶受体拮抗剂的硫酸氢盐的结晶多态性,制备相同的药物组合物和抑制凝血酶受体的药物组合物的过程

摘要

A crystalline polymorph of a bislulfate salt of a thrombin receptor antagonist compound, which exhibits a powder x-ray diffraction profile substantially the same as that shown in FIG. 1, or which exhibits a differential scanning calorimtery profile substantially the same as that shown in FIG. 3, and is represented by the formula for Compound 2: Chemical formula should be inserted here as it appears on the abstract in paper form. and processes for preparing Compound 2 are disclosed. Pharmaceutical compositions comprising the polymorph of the bisulfate salt and at least one excipient or carrier, and methods of using the polymorph of Compound 2 to treat a variety of physiological disorders, such as thrombosis, are also disclosed.
机译:凝血酶受体拮抗剂化合物的二硫酸氢盐的结晶多晶型物,其粉末X射线衍射图谱与图1所示的基本相同。示于图1中,或表现出与图1所示基本相同的差示扫描量热曲线。 3,由化合物2的式子表示:化学式应以书面形式出现在摘要上。公开了制备化合物2的方法。还公开了包含硫酸氢盐的多晶型物和至少一种赋形剂或载体的药物组合物,以及使用化合物2的多晶型物治疗多种生理疾病,例如血栓形成的方法。

著录项

  • 公开/公告号IL176726B

    专利类型

  • 公开/公告日2012-08-30

    原文格式PDF

  • 申请/专利权人 SCHERING CORPORATION;

    申请/专利号IL176726

  • 发明设计人

    申请日2006-07-06

  • 分类号A61P7/02;A61P9/00;A61P9/04;A61P9/06;A61P9/10;A61P9/12;A61P13/12;A61P35/00;A61P43/00;C07D405/06;C07D405/14;C07D413/14;C07D417/14;C07D521/00;

  • 国家 IL

  • 入库时间 2022-08-21 17:24:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号